Skip to the reading

Guidebook · Approval notes

Taking back a request does not give pharmacies permission.

Compounding means preparing medicine to order for one patient. A pharmacy must also meet rules about which ingredients it may use.

The misconception

Misconception: BPC-157 is allowed in pharmacy-made medicine because it left the FDA’s group of ingredients with serious safety concerns.

What holds up

Check permission to use the ingredient.

On its page marked current on April 22, 2026, the FDA says groups withdrew requests to add BPC-157 to a list of allowed pharmacy ingredients.

This means the groups took back their requests. The page no longer puts BPC-157 in the group for ingredients with serious safety concerns. It still lists worries about the body reacting to BPC-157 and unwanted substances mixed into it.

As of September 2026, the federal rule and FDA records show that BPC-157 fails the ingredient requirements when a pharmacy prepares medicine for one patient.

Evidence · A

The three ingredient requirements

The FDA reviewed two different ingredients that both use the BPC-157 name. The distinction concerns the ingredient itself, rather than its use in a pill versus a shot. FDA treats the two as different ingredients.

When a pharmacy makes medicine from raw ingredients for an individual patient, each ingredient must meet one of these requirements.

  • First: an official written standard for the ingredient.

    A standard is an official set of written requirements for a drug ingredient. In July 2026, FDA found no such standard for either BPC-157 version it reviewed.

  • If no standard exists: an approved drug must contain the ingredient.

    As of September 2026, neither version of BPC-157 is used as an ingredient in a drug approved by the FDA.

  • If neither applies: an entry on the FDA’s allowed-ingredient list.

    The FDA’s list of allowed raw ingredients for pharmacies making medicine for individual patients has no BPC-157 entry, as of September 2026.

A pharmacy’s ability to mix medicine does not mean it may use every ingredient.

Evidence · B

What a committee meeting can decide

In July 2026, FDA staff recommended keeping both BPC-157 versions off the list of ingredients for pharmacies making medicine for individual patients.

As of September 28, 2026, FDA had not published an official record of the committee’s votes.

The committee’s vote provides advice for the FDA. Under the rules checked in September 2026, the FDA must formally change the regulation to change the ingredient list. That process invites public comments.

Ask the pharmacy to name the rule that lets it use this exact ingredient for you. Ask which requirement it meets and where you can check that in the official records.

Evidence · C

Page evidence

  1. FDA table: withdrawn ingredient requests

    Read the withdrawn-request table and the concerns beside the ingredient.

  2. FDA: ingredient rules for medicine made for one patient

    Use this FDA page to check which ingredient requirement a pharmacy says it meets. A request to add an ingredient is different from permission to use it.

  3. FDA: committee meeting materials

    The meeting page is the place to look for official records beyond the staff briefing.